The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Icon, the Dublin-based clinical trials for pharmaceutical groups globally, has confirmed that revenue accounting issues ...

Investing.com - Truist Securities has reiterated its Hold rating and $222.00 price target on ICON plc (NASDAQ:ICLR) following the company’s internal investigation announcement regarding revenue ...

Investing.com - BMO Capital has lowered its price target on ICON plc (NASDAQ:ICLR) to $100.00 from $175.00 while maintaining a Market Perform rating amid an ongoing accounting investigation. The stock ...

Investigation’s preliminary indications are that 2023 and 2024 revenue may have been overstated by less than 2% for each fiscal year ICON plc, (NASDAQ: ICLR) today announced that it intends to release ...

Icon Plc ICLR shares are crashing in Thursday’s premarket session as the company disclosed an update on its upcoming earnings report. The clinical research organisation disclosed an ongoing internal ...

Icon's stock plummeted about 40% on Feb. 12, as the firm announced an accounting investigation initiated by the Audit Committee of Icon's board of directors. Preliminary results indicate the company's ...